The North America Blood Plasma Derivatives Market would witness market growth of 8.9% CAGR during the forecast period (2022-2028).
Plasma is a transparent, straw-colored liquid component of blood that is composed of a protein salt solution. There are three kinds of blood cells floating in plasma, including white blood cells, red blood cells, and platelets. More than 100 distinct proteins, including albumin, immunoglobulin, fibrinogen, protease inhibitors, and clotting factor, are present in plasma.
It is essential for regulating blood pressure and transferring minerals, such as salt and potassium. Plasma is a liquid component of blood that includes platelets and proteins responsible for blood coagulation. Plasma Derivatives are derived from plasma proteins during the fractionation cycle. The Derivatives are then heat- or chemically-treated dissolvable cleaners that kill certain diseases.
Factor IX concentrate, factor VIII concentrate, hostile to inhibitor coagulation complex (AICC), Alpha 1-Proteinase inhibitor concentrate, against thrombin III concentrate, egg whites, insusceptible globulins, and against thrombin III concentrates are the most well-known plasma derivatives. Clinically, blood plasma derivatives are widely used to treat a variety of illnesses, including HIV, hemophilia A, thrombocytosis, hemophilia B, hepatitis C, hepatitis B, etc.
The North American blood plasma derivatives market is estimated to witness a number of growth prospects throughout the coming years. The regional market is anticipated to grow significantly as a result of rising knowledge about the usage as well as availability of plasma derivatives across the region, as well as the high adoption of sophisticated technology, and the presence of significant manufacturing companies and key market players. Therefore, all of these factors would play a major role in bolstering the growth of the regional blood plasma derivatives market.
The US market dominated the North America Blood Plasma Derivatives Market by Country in 2021; thereby, achieving a market value of $19,716.5 Million by 2028. The Canada market is experiencing a CAGR of 11.4% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 10.4% during (2022 - 2028).
Based on Application, the market is segmented into Immunodeficiency Diseases, Hypogammaglobulinemia, Hemophilia, Von Willebrand's Disease, and Others. Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Type, the market is segmented into Immunoglobulin, Albumin, Factor VIII, Factor IX, Hyperimmune Globulin, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Blood Plasma Derivatives Market is Predict to reach $72.5 Billion by 2028, at a CAGR of 9.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Takeda Pharmaceutical Company Limited, Grifols, S.A., Biotest AG, LFB S.A., CSL Limited, Octapharma AG, Kedrion S.p.A, Sanofi S.A. and Fusion Health Care Pvt. Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Immunodeficiency Diseases
- Hypogammaglobulinemia
- Hemophilia
- Von Willebrand's Disease
- Others
By End User
By Type
- Immunoglobulin
- Albumin
- Factor VIII
- Factor IX
- Hyperimmune Globulin
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Bayer AG
- Takeda Pharmaceutical Company Limited
- Grifols, S.A.
- Biotest AG
- LFB S.A.
- CSL Limited
- Octapharma AG
- Kedrion S.p.A
- Sanofi S.A.
- Fusion Health Care Pvt. Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Blood Plasma Derivatives Market, by Application
1.4.2 North America Blood Plasma Derivatives Market, by End User
1.4.3 North America Blood Plasma Derivatives Market, by Type
1.4.4 North America Blood Plasma Derivatives Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Blood Plasma Derivatives Market
Chapter 4. North America Blood Plasma Derivatives Market by Application
4.1 North America Immunodeficiency Diseases Market by Country
4.2 North America Hypogammaglobulinemia Market by Country
4.3 North America Hemophilia Market by Country
4.4 North America Von Willebrand's Disease Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Blood Plasma Derivatives Market by End User
5.1 North America Hospitals Market by Country
5.2 North America Clinics Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Blood Plasma Derivatives Market by Type
6.1 North America Immunoglobulin Market by Country
6.2 North America Albumin Market by Country
6.3 North America Factor VIII Market by Country
6.4 North America Factor IX Market by Country
6.5 North America Hyperimmune Globulin Market by Country
6.6 North America Others Market by Country
Chapter 7. North America Blood Plasma Derivatives Market by Country
7.1 US Blood Plasma Derivatives Market
7.1.1 US Blood Plasma Derivatives Market by Application
7.1.2 US Blood Plasma Derivatives Market by End User
7.1.3 US Blood Plasma Derivatives Market by Type
7.2 Canada Blood Plasma Derivatives Market
7.2.1 Canada Blood Plasma Derivatives Market by Application
7.2.2 Canada Blood Plasma Derivatives Market by End User
7.2.3 Canada Blood Plasma Derivatives Market by Type
7.3 Mexico Blood Plasma Derivatives Market
7.3.1 Mexico Blood Plasma Derivatives Market by Application
7.3.2 Mexico Blood Plasma Derivatives Market by End User
7.3.3 Mexico Blood Plasma Derivatives Market by Type
7.4 Rest of North America Blood Plasma Derivatives Market
7.4.1 Rest of North America Blood Plasma Derivatives Market by Application
7.4.2 Rest of North America Blood Plasma Derivatives Market by End User
7.4.3 Rest of North America Blood Plasma Derivatives Market by Type
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.2 Takeda Pharmaceutical Company Limited
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Grifols, S.A
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Biotest AG (Tiancheng International Investment Limited)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.5 LFB S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 CSL Limited (CSL Behring)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Octapharma AG
8.7.1 Company Overview
8.8 Kedrion S.p.A
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Product Launches and Product Expansions:
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fusion Health Care Pvt. Ltd.
8.10.1 Company Overview
TABLE 1 North America Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 2 North America Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 3 North America Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 4 North America Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 5 North America Immunodeficiency Diseases Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Immunodeficiency Diseases Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Hypogammaglobulinemia Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Hypogammaglobulinemia Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Von Willebrand's Disease Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Von Willebrand's Disease Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 16 North America Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 17 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Clinics Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Clinics Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 24 North America Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 25 North America Immunoglobulin Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Immunoglobulin Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Albumin Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Albumin Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Factor VIII Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Factor VIII Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Factor IX Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Factor IX Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Hyperimmune Globulin Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Hyperimmune Globulin Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Blood Plasma Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Blood Plasma Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 39 US Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 40 US Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 41 US Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 42 US Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 43 US Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 44 US Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 45 US Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 46 US Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 47 Canada Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 48 Canada Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 49 Canada Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 50 Canada Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 51 Canada Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 52 Canada Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 53 Canada Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 54 Canada Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 55 Mexico Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 56 Mexico Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 57 Mexico Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 58 Mexico Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 59 Mexico Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 60 Mexico Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 61 Mexico Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 62 Mexico Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 63 Rest of North America Blood Plasma Derivatives Market, 2018 - 2021, USD Million
TABLE 64 Rest of North America Blood Plasma Derivatives Market, 2022 - 2028, USD Million
TABLE 65 Rest of North America Blood Plasma Derivatives Market by Application, 2018 - 2021, USD Million
TABLE 66 Rest of North America Blood Plasma Derivatives Market by Application, 2022 - 2028, USD Million
TABLE 67 Rest of North America Blood Plasma Derivatives Market by End User, 2018 - 2021, USD Million
TABLE 68 Rest of North America Blood Plasma Derivatives Market by End User, 2022 - 2028, USD Million
TABLE 69 Rest of North America Blood Plasma Derivatives Market by Type, 2018 - 2021, USD Million
TABLE 70 Rest of North America Blood Plasma Derivatives Market by Type, 2022 - 2028, USD Million
TABLE 71 Key Information – Bayer AG
TABLE 72 Key Information – Takeda Pharmaceutical Company Limited
TABLE 73 Key information – Grifols, S.A.
TABLE 74 key information – Biotest AG
TABLE 75 Key Information – LFB S.A
TABLE 76 key Information – CSL Limited
TABLE 77 Key Information – Octapharma AG
TABLE 78 key Information – Kedrion S.p.A
TABLE 79 Key Information – Sanofi S.A.
TABLE 80 Key Information – Fusion Health Care Pvt. Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Grifols, S.A.
FIG 3 Recent strategies and developments: Kedrion S.p.A